The small study involved seven military personnel — five veterans and two active duty — who’d had brain injuries and experienced CTE-type symptoms, such as memory loss and mood swings. They were injected with FDDNP. The FDDNP tracer binds with the abnormal proteins in the brain and then appears in neural PET scans. {read more here}